Previous 10 | Next 10 |
LYON, France, December 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Lance Willsey, M.S., M.D. to its Board of Directors. Dr. Willsey replaces Dr. Argil Whee...
LYON, France, November 30, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that is has received the Industry Category Award from the French National Institute for Intellectual Property (INPI) based on the Company ...
LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Piper Sandler 3...
2023-11-09 13:20:10 ET EDAP TMS S.A. (EDAP) Q3 2023 Earnings Conference Call November 09, 2023, 08:30 ET Company Participants John Fraunces - LifeSci Advisors Ryan Rhodes - CEO Ken Mobeck - CFO, US Subsidiary Conference Call Participants Michael Sarco...
2023-11-09 06:19:22 ET More on EDAP TMS S.A. EDAP: Expecting Commercial Success In Prostate Cancer With Pipeline Expansion EDAP: French Company And A Solid Revenue Generator In Its Niche Seeking Alpha’s Quant Rating on EDAP TMS S.A. For further details...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
- Strong Q3 2023 U.S. Focal One ® HIFU procedure growth of +150% year-over-year - - Record nine months HIFU revenues reflecting growing demand - - Two additional Focal One systems already placed in the fourth quarter - - Announces immunotherapy clinical ...
EDAP TMS S.A. (EDAP) is expected to report $-0.11 for Q3 2023
2023-11-08 11:58:27 ET More on EDAP TMS S.A. EDAP: Expecting Commercial Success In Prostate Cancer With Pipeline Expansion Seeking Alpha’s Quant Rating on EDAP TMS S.A. For further details see: EDAP TMS S.A. Q3 2023 Earnings Preview
LYON, France, November 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies London...
News, Short Squeeze, Breakout and More Instantly...
EDAP TMS S.A. Company Name:
EDAP Stock Symbol:
NASDAQ Market:
2024-05-06 08:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Final results demonstrate a significantly higher salvage treatment free survival rate (STFS) at 30 months of 89.6% in the HIFU-treated arm versus 86.2% in patients who underwent radical prostatectomy (RP) Functional evaluation criteria sho...
Company to host conference call and webcast on Thursday, May 16 th at 8:30am EDT LYON, France, May 2, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results...